Department of Surgery, Keio University School of Medicine, Keio University Hospital, Tokyo, Japan.
Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Br J Surg. 2020 May;107(6):705-711. doi: 10.1002/bjs.11487. Epub 2020 Feb 20.
Oesophageal squamous cell carcinoma is an aggressive disease owing to early and widespread lymph node metastases. Multimodal therapy and radical surgery may improve prognosis. Few studies have investigated the efficacy of radical lymph node and thoracic duct resection.
Patients with oesophageal squamous cell carcinoma who underwent transthoracic minimally invasive oesophagectomy (TMIE) for cancer at Keio University Hospital between January 2004 and December 2016 were selected. Between 2004 and 2008, TMIE was performed in the lateral decubitus position without thoracic duct resection (standard TMIE). From 2009 onwards, TMIE with extended lymph node and thoracic duct resection was introduced (extended TMIE). Demographics, co-morbidity, number of retrieved lymph nodes, pathology, postoperative complications and recurrence-free survival (RFS) were compared between groups.
Forty-four patients underwent standard TMIE and 191 extended TMIE. There were no significant differences in clinical and pathological tumour stage or postoperative complications. The extended-TMIE group had more lymph nodes removed at nodal stations 106recL and 112. Among patients with cT1 N0 disease, RFS was better in the extended-TMIE group (P < 0·001), whereas there was no difference in RFS between groups in patients with advanced disease.
Extended TMIE including thoracic duct resection increased the number of lymph nodes retrieved and was associated with improved survival in patients with cT1 N0 oesophageal squamous cell carcinoma.
食管鳞状细胞癌由于早期广泛的淋巴结转移而具有侵袭性。多模式治疗和根治性手术可能改善预后。很少有研究探讨根治性淋巴结和胸导管切除术的疗效。
选择 2004 年 1 月至 2016 年 12 月期间在庆应义塾大学医院接受经胸微创食管切除术(TMIE)治疗癌症的食管鳞状细胞癌患者。2004 年至 2008 年,在侧卧位不进行胸导管切除的情况下进行 TMIE(标准 TMIE)。从 2009 年开始,引入了扩展淋巴结和胸导管切除术的 TMIE(扩展 TMIE)。比较两组患者的人口统计学、合并症、淋巴结检出数量、病理、术后并发症和无复发生存率(RFS)。
44 例患者接受了标准 TMIE,191 例患者接受了扩展 TMIE。两组在临床和病理肿瘤分期或术后并发症方面无显著差异。扩展 TMIE 组在淋巴结站 106recL 和 112 处检出的淋巴结更多。在 cT1N0 疾病患者中,扩展 TMIE 组的 RFS 更好(P<0·001),而在晚期疾病患者中,两组的 RFS 无差异。
包括胸导管切除的扩展 TMIE 增加了淋巴结检出数量,并与 cT1N0 食管鳞状细胞癌患者的生存改善相关。